skip to main content
Show Results with:

Evaluation of efficacy and safety of orlistat in obese patients

Indian Journal of Endocrinology and Metabolism, 2011, Vol.15(2), p.99-104 [Peer Reviewed Journal]

No full-text

  • Title:
    Evaluation of efficacy and safety of orlistat in obese patients
  • Author: Jain, Suyog ; Ramanand, Sunita ; Ramanand, Jaiprakash ; Akat, Pramod ; Patwardhan, Milind ; Joshi, Sachin
  • Found In: Indian Journal of Endocrinology and Metabolism, 2011, Vol.15(2), p.99-104 [Peer Reviewed Journal]
  • Subjects: Antiobesity agents; obesity; orlistat; weight loss
  • Description: Context: Rapidly rising prevalence of obesity is alarming. Obesity predisposes to co-morbidities like hypertension, type 2 diabetes mellitus, dyslipidemias, thus substantially rising healthcare expenditure. Lifestyle modifications alone have very limited success, necessitating the addition of pharmacotherapy to it. Objective: Present study was carried out to evaluate the efficacy and safety of orlistat in obese patients. Materials and Methods: Eighty obese (BMI>30) patients according to inclusion and exclusion criteria were randomized into either of the two groups. Group 1 received orlistat 120 mg three times a day and group 2 received placebo three times a day. Weight, waist circumference, BMI, total cholesterol, triglycerides, HDL, LDL were measured at baseline and then at 8 th , 16 th and 24 th week. ADR reported by patients were recorded. For safety evaluation various hematological and biochemical parameters were assessed. Z test was used for analysis of data. Results: Compared to placebo, orlistat caused significant reduction (P<0.05) in weight (4.65 kg vs 2.5 kg; orlistat vs placebo, respectively), BMI (1.91 kg/m 2 vs 0.64 kg/m 2 ) and waist circumference (4.84 cm vs 2 cm), cholesterol (10.68 mg vs 6.18 mg) and LDL level (5.87 mg vs 2.33 mg). In the orlistat group, the GI side effects like loose stools, oily stools/spotting, abdominal pain and fecal urgency were observed. Conclusion: Orlistat is an effective and well-tolerated antiobesity drug, which can be employed as an adjunct to therapeutic lifestyle changes to achieve and maintain optimal weight.
  • Identifier: ISSN: 2230-8210 ; DOI: 10.4103/2230-8210.81938

Searching Remote Databases, Please Wait